Nanoparticle News and Research

RSS

In nanotechnology, a particle is defined as a small object that behaves as a whole unit in terms of its transport and properties. It is further classified according to size: in terms of diameter, fine particles cover a range between 100 and 2500 nanometers, while ultrafine particles, on the other hand, are sized between 1 and 100 nanometers.

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.

4 Dec 2018

Using nanocarrier-delivered microRNA to target sepsis

One in three patients who die in the U.S. dies of sepsis, according to the Centers for Disease Control and Prevention. It is one of the leading causes of death in intensive care units and, with an estimated price tag of $20 billion in 2011, the most expensive condition that hospitals treat.

3 Dec 2018

New nanoscale technique developed to get more information from the blood of cancer patients

A technique to get more information from the blood of cancer patients than previously possible has been developed.

28 Nov 2018

NanoSphere develops new intraoral product that has potential to revolutionize cannabis therapies

NanoSphere Health Sciences Inc. is pleased to announce the Company has developed a new intraoral delivered cannabis product for the Canadian market, which produces similar effects to smoking cannabis, but is safer and more effective than edibles.

26 Nov 2018

Scripps Research scientists reveal potential new approach to design HIV vaccines

A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.

26 Nov 2018

New technology based on moths and magnets could help treat genetic diseases

A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis.

14 Nov 2018

Scientists examine FCMs containing silver nanoparticles

Because of their antimicrobial and antifungal properties, silver nanoparticles measuring between one and 100 nanometers in size, are being incorporated outside the United States into a variety of kitchen products known as food contact materials.

9 Nov 2018

Study uses gold nanoparticles to remove prostate cancer cells

A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth). It is the first trial of its kind in the world.

9 Nov 2018

Researchers find new tiny molecule that is capable of killing medulloblastoma

A new study by UT Health San Antonio researchers found that a molecule thousands of times smaller than a gene is able to kill medulloblastoma, the most common childhood brain cancer.

8 Nov 2018

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Nanoparticles that could reprogram a cancer patient's immune system inside their own body. Understanding a mysterious type of brain cell in the hopes of shedding new light on Alzheimer's disease. Reimagining nuclei, the DNA-storage compartments of our cells, as miniature lava lamps.

30 Oct 2018

Silver nanoparticles coated with anti-seizure drugs can kill brain-eating amoebae

Halloween is just around the corner, and some people will celebrate by watching scary movies about brain-eating zombies.

24 Oct 2018

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.

24 Oct 2018

Researchers identify a new way to prolong the circulation of cancer-fighting nanoparticles in the bloodstream

For a number of innovative and life-saving medical treatments, from organ replacements and skin grafts to cancer therapy and surgery, success often depends on slipping past or fending off the body's immune system.

24 Oct 2018

Scientists develop dual anthrax-plague vaccine

A team of researchers has now engineered a virus nanoparticle vaccine against Bacillus anthracis and Yersinia pestis, tier 1 agents that pose serious threats to national security of the United States. B. anthracis and Y. pestis are the pathogens that cause anthrax and plague, respectively.

16 Oct 2018

Cornell dots equipped with antibody fragments offer a new cancer weapon

Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety.

12 Oct 2018

Researchers devise a simple way to boost efficacy of malarial TBVs

For decades, scientists have been trying to develop a vaccine that prevents mosquitoes from spreading malaria among humans.

9 Oct 2018

New method for quantification of liposome formulated drugs

Postnova Analytics has published an application study that describes a new method for quantification of liposome encapsulated drug using Centrifugal Field-Flow Fractionation

From Postnova Analytics 5 Oct 2018

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast cancer cells test negative for estrogen and progesterone receptors as well as HER2 receptors, genes that can play a role in the development of breast cancer.

1 Oct 2018

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.

27 Sep 2018

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.

24 Sep 2018

Nanoparticle News and Research

Further Reading

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Using nanocarrier-delivered microRNA to target sepsis

New nanoscale technique developed to get more information from the blood of cancer patients

NanoSphere develops new intraoral product that has potential to revolutionize cannabis therapies

Scripps Research scientists reveal potential new approach to design HIV vaccines

New technology based on moths and magnets could help treat genetic diseases

Scientists examine FCMs containing silver nanoparticles

Study uses gold nanoparticles to remove prostate cancer cells

Researchers find new tiny molecule that is capable of killing medulloblastoma

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Silver nanoparticles coated with anti-seizure drugs can kill brain-eating amoebae

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Researchers identify a new way to prolong the circulation of cancer-fighting nanoparticles in the bloodstream

Scientists develop dual anthrax-plague vaccine

Cornell dots equipped with antibody fragments offer a new cancer weapon

Researchers devise a simple way to boost efficacy of malarial TBVs

New method for quantification of liposome formulated drugs

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

A practical guide to lipid nanoparticle formulation and resizing eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery